Free Trial

Canopy Growth (TSE:WEED) Stock Price Down 9.5% - Time to Sell?

Canopy Growth logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Shares fell 9.5% to C$1.71 on Thursday with about 10.3M shares traded, roughly a 357% increase versus average volume, signaling a heavy intraday sell-off.
  • Analysts are mixed but mildly positive: the consensus rating is a “Moderate Buy” with an average price target of C$1.97 (two Buys, one Hold).
  • Financials show ongoing weakness — market cap C$710M, last quarter EPS of C($0.18) and projected FY EPS of -0.69, with negative net margin and ROE, although liquidity ratios are strong (current ratio 5.34, quick ratio 2.32).
  • Five stocks to consider instead of Canopy Growth.

Shares of Canopy Growth Corp (TSE:WEED - Get Free Report) were down 9.5% on Thursday . The stock traded as low as C$1.71 and last traded at C$1.71. Approximately 10,335,667 shares changed hands during mid-day trading, an increase of 357% from the average daily volume of 2,261,944 shares. The stock had previously closed at C$1.89.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on WEED shares. ATB Cormark Capital Markets raised Canopy Growth from a "sector perform" rating to an "outperform" rating and set a C$1.40 price objective for the company in a research report on Tuesday, March 17th. Canaccord Genuity Group set a C$2.00 price objective on Canopy Growth and gave the stock a "speculative buy" rating in a research report on Friday, March 27th. Finally, Sanford C. Bernstein lowered their price objective on Canopy Growth from C$5.30 to C$2.50 in a research report on Wednesday, January 14th. Two analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, Canopy Growth currently has a consensus rating of "Moderate Buy" and an average price target of C$1.97.

Read Our Latest Research Report on Canopy Growth

Canopy Growth Price Performance

The firm has a market capitalization of C$710.34 million, a P/E ratio of -0.90, a price-to-earnings-growth ratio of -0.01 and a beta of 1.45. The business has a 50-day moving average of C$1.47 and a 200 day moving average of C$1.64. The company has a current ratio of 5.34, a quick ratio of 2.32 and a debt-to-equity ratio of 35.93.

Canopy Growth (TSE:WEED - Get Free Report) last issued its earnings results on Friday, February 6th. The company reported C($0.18) EPS for the quarter. Canopy Growth had a negative net margin of 117.31% and a negative return on equity of 52.88%. The firm had revenue of C$74.54 million during the quarter. On average, sell-side analysts predict that Canopy Growth Corp will post -0.69 earnings per share for the current fiscal year.

Canopy Growth Company Profile

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines